Search

Search Constraints

You searched for: Author/Creator Constantin, Tamas

Search Results

1. AB0966 PROPOSAL OF OUTCOME MEASURES TO BE USED ON A 12-MONTH OPEN LABEL DRUG TRIAL IN JUVENILE SYSTEMIC SCLEROSIS. RESULTS OF THE 3RD CONSENSUS MEETING IN HAMBURG DECEMBER 2018. (June 2019)

2. Consensus-based recommendations for the management of juvenile dermatomyositis. Issue 2 (11th August 2016)

3. Consensus-based recommendations for the management of juvenile systemic sclerosis. (4th November 2020)

4. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Issue 8 (28th March 2018)

5. Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. Issue 2 (30th October 2017)

6. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Issue 6 (21st May 2013)

7. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Issue 4 (1st November 2016)

8. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. (11th September 2021)

9. Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial. (23rd September 2021)

10. OP0058 DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH ETANERCEPT IN PATIENTSWITH JUVENILE IDIOPATHIC ARTHRITIS. (June 2019)